Clinical Trials in Seattle

Showing 7361-7380 of 9,312 trials

Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer

NCT02101593

Assessment of safety and tolerability of ADI-PEG 20 in combination with sorafenib in advanced Hepatocellular Carcinoma (HCC).

Hepatocellular Carcinoma

Polaris Group8 participantsStarted Nov 2014

New York, New York, United States • Seattle, Washington, United States

COMPLETEDNA< 1 mile

Supportive Care for Patients With Hematological Malignancies Undergoing Hematopoietic Cell Transplant

NCT01758484

This pilot clinical trial studies supportive care for patients with hematological malignancies undergoing hematopoietic cell transplant. Supportive care may improve quality of life in this patient population.

Hematopoietic/Lymphoid Cancer

Fred Hutchinson Cancer Center20 participantsStarted Apr 2013

Seattle, Washington, United States

COMPLETEDNA< 1 mile

Glucose Meter Study

NCT00782496

The purpose of this study is to evaluate if the meal marker and reminder feature of the Contour meter along with education maintains or increases frequency of testing blood sugar after meals and enables behavioral changes that may lead to improvement in glycemic control.

Diabetes Mellitus

Ascensia Diabetes Care211 participantsStarted Nov 2008

Atlanta, Georgia, United States • Minneapolis, Minnesota, United States • New York, New York, United States +1 more locations

COMPLETEDPhase 4< 1 mile

ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.

NCT00077636

This study will evaluate the efficacy and safety of different durations of treatment with PEGASYS combined with ribavirin in patients with CHC genotype 2 or 3 infection who have never previously received interferon (IFN) therapy. The anticipated time on study treatment is 3-12 months and the target sample size is 500+ individuals.

Hepatitis C, Chronic

Hoffmann-La Roche1,469 participantsStarted Dec 2003

Birmingham, Alabama, United States • Mobile, Alabama, United States • Anchorage, Alaska, United States +129 more locations

Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer

Supportive Care for Patients With Hematological Malignancies Undergoing Hematopoietic Cell Transplant

Glucose Meter Study

ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.

Find Trials by Condition in Seattle

Blood and Marrow Transplant Clinical Research Network

Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Expressive Writing in Improving the Wellbeing or Comforting Capacity of Caregivers of Patients With Cancer

Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus

Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)

First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma

Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults

The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus

Imatinib (QTI571) in Pulmonary Arterial Hypertension

Atacicept in Subjects With Optic Neuritis

Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2

A Phase IIa Repeat Dose AXP1275 vs Placebo Cross-over Trial With Pulmonary Allergen Challenge in Adults With Asthma

Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)

Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy

A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.